Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

NCT01814475

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +8 more
Locations
  • Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy
  • Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy
  • Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy
  • AO Spedali Civili di Brescia- USD - TMO Adulti Brescia, Italy
View all 21 locations
View Trial Details
Completed

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

NCT03647215

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +20 more
Locations
  • Limerick University Hospital Limerick, Dooradoyle, Ireland
  • University Hospital Waterford Waterford, Ireland
  • Royal Cornwall Hospital Truro, Cornwall, United Kingdom
  • Royal Devon & Exeter Hospital Exeter, Devon, United Kingdom
View all 33 locations
View Trial Details
Completed

Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®

NCT01352585

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Azienda Ospedaliera Policlinico di Bari Bari, Italy
  • Istituto Seragnoli-Policlinico S.Orsola-Malpighi Bologna, Italy
  • A.O. Spedali Civili di Brescia Brescia, Italy
  • Azienda Ospedaliero-Universitaria Careggi Florence, Italy
View Trial Details
Completed

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

NCT00171249

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +23 more
Locations
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • New York Presbyterian Hospital New York, United States
  • Oregon Health & Sciences University Portland, Oregon, United States
  • MD Anderson Cancer Center, University of Texas Houston, Texas, United States
View Trial Details
Completed

An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

NCT00171223

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +20 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • H. Lee Moffet Cancer Center & Research Institute/Univ of South Florida Tampa, Florida, United States
  • Northwestern Univ meical School/Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
View all 28 locations
View Trial Details
Completed

Anagre Cap. in Patients With High-Risk Essential Thrombocythemia

NCT03232177

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • National Health Insurance Service Ilsan Hospital Goyang-si, Gyeonggi-do, South Korea
  • The Catholic University of Korea. ST. Vincents Hospital Suwon, Gyeonggi-do, South Korea
  • Hallym UNIV. Medical Center Anyang, South Korea
  • Daegu Catholic University Medical Center Daegu, South Korea
View all 21 locations
View Trial Details
Completed

A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.

NCT01743989

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +17 more
Locations
  • Novartis Investigative Site Linz, Upper Austria, Austria
  • Novartis Investigative Site Graz, Austria
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Linz, Austria
View all 208 locations
View Trial Details
Completed

Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

NCT01690520

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +22 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of Colorado Denver, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions